Literature DB >> 8322653

Comparative hemodynamic effects of amiodarone, sotalol, and d-sotalol.

N Twidale1, P Roberts-Thomson, R J McRitchie.   

Abstract

The effects of intravenous boluses of amiodarone (5 mg/kg), racemic sotalol (enantiomeric ratio d/l-sotalol 1:1;1.5 mg/kg), and d-sotalol (0.75 mg/kg) on mean arterial pressure (MAP), heart rate (HR), cardiac output (CO), total peripheral resistance (TPR), left ventricular end-diastolic pressure (LVEDP), and peak rate of change of left ventricular pressure (LV dp/dt) were assessed in conscious rabbits. Amiodarone and sotalol had a modest negative inotropic effect: amiodarone reduced peak LV dp/dt by 8 +/ 2% (mean +/- SEM) (p < 0.05) and sotalol by 6 +/- 2% (p < 0.05). These two drugs had quite different effects on CO as a result of differences in their actions on peripheral blood vessels: amiodarone caused a 13 +/- 3% (p < 0.05) increase in CO associated with a substantial vasodilatory effect (TPR reduced 25 +/- 3%; p < 0.01); sotalol did not produce any substantial change in either CO or TPR. Bolus intravenous injection of amiodarone was associated with a significant increase in HR (12 +/- 3%; p < 0.01), whereas sotalol reduced HR by 7 +/- 1% (p < 0.05). In contrast, administration of the dextro-rotatory optical isomer, d-sotalol, produced no significant change in peak LV dp/dt, LVEDP, CO, TPR, or HR. These results confirm that amiodarone and racemic sotalol have a comparatively weak cardiodepressant action. The experiments also show that the reduction in cardiac performance associated with racemic sotalol is mediated predominantly through the beta-adrenoreceptor blocking action of the levo-rotatory isomer (l-sotalol) rather than any substantial cardiodepressant effect of the dextro-rotatory isomer.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8322653     DOI: 10.1016/s0002-8703(07)80018-4

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  3 in total

Review 1.  Sotalol. An updated review of its pharmacological properties and therapeutic use in cardiac arrhythmias.

Authors:  A Fitton; E M Sorkin
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

2.  Acute hemodynamic effects of intravenous amiodarone treatment in paediatric cardiac surgical patients.

Authors:  Nikolaus A Haas; Christoph K Camphausen
Journal:  Clin Res Cardiol       Date:  2008-06-05       Impact factor: 5.460

3.  ECMO for cardiac rescue in a neonate with accidental amiodarone overdose.

Authors:  Nikolaus Alexander Haas; Christine Wegendt; Rainer Schäffler; Günther Kirchner; Eva Welisch; Katharina Kind; Ute Blanz; Deniz Kececioglu
Journal:  Clin Res Cardiol       Date:  2008-08-18       Impact factor: 5.460

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.